DE60130669D1 - Polysaccharide mit antithrombotischer wirkung, die mit biotin oder einem biotenderivat kovalent gebunden sind - Google Patents

Polysaccharide mit antithrombotischer wirkung, die mit biotin oder einem biotenderivat kovalent gebunden sind

Info

Publication number
DE60130669D1
DE60130669D1 DE60130669T DE60130669T DE60130669D1 DE 60130669 D1 DE60130669 D1 DE 60130669D1 DE 60130669 T DE60130669 T DE 60130669T DE 60130669 T DE60130669 T DE 60130669T DE 60130669 D1 DE60130669 D1 DE 60130669D1
Authority
DE
Germany
Prior art keywords
polycharcharides
bioten
kovalent
antithrombotic
biotin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60130669T
Other languages
English (en)
Other versions
DE60130669T2 (de
Inventor
Philippe Duchaussoy
Jean-Marc Herbert
Maurice Petitou
Pierre Savi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Application granted granted Critical
Publication of DE60130669D1 publication Critical patent/DE60130669D1/de
Publication of DE60130669T2 publication Critical patent/DE60130669T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE60130669T 2000-09-22 2001-09-20 Polysaccharide mit antithrombotischer wirkung, die mit biotin oder einem biotinderivat kovalent gebunden sind Expired - Lifetime DE60130669T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0012094A FR2814463B1 (fr) 2000-09-22 2000-09-22 Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
FR0012094 2000-09-22
PCT/FR2001/002918 WO2002024754A1 (fr) 2000-09-22 2001-09-20 Polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Publications (2)

Publication Number Publication Date
DE60130669D1 true DE60130669D1 (de) 2007-11-08
DE60130669T2 DE60130669T2 (de) 2008-07-17

Family

ID=8854579

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130669T Expired - Lifetime DE60130669T2 (de) 2000-09-22 2001-09-20 Polysaccharide mit antithrombotischer wirkung, die mit biotin oder einem biotinderivat kovalent gebunden sind

Country Status (40)

Country Link
US (3) US6844329B2 (de)
EP (1) EP1322673B1 (de)
JP (2) JP5016778B2 (de)
KR (2) KR100891388B1 (de)
CN (1) CN1235914C (de)
AR (1) AR030774A1 (de)
AT (1) ATE374215T1 (de)
AU (2) AU9196001A (de)
BG (1) BG66191B1 (de)
BR (1) BR0114007A (de)
CA (1) CA2418815C (de)
CY (1) CY1108076T1 (de)
CZ (1) CZ300856B6 (de)
DE (1) DE60130669T2 (de)
DK (1) DK1322673T3 (de)
EA (1) EA005133B1 (de)
EC (1) ECSP034514A (de)
EE (1) EE05202B1 (de)
ES (1) ES2292625T3 (de)
FR (1) FR2814463B1 (de)
GE (1) GEP20053616B (de)
HK (1) HK1053316A1 (de)
HR (1) HRP20030219B1 (de)
HU (2) HU1400034D0 (de)
IL (2) IL154848A0 (de)
IS (1) IS2550B (de)
ME (2) MEP23608A (de)
MX (1) MXPA03002483A (de)
NO (2) NO332905B1 (de)
NZ (1) NZ524472A (de)
PE (1) PE20020471A1 (de)
PL (1) PL206727B1 (de)
PT (1) PT1322673E (de)
RS (1) RS50730B (de)
SI (1) SI1322673T1 (de)
SK (2) SK287054B6 (de)
TW (1) TWI308153B (de)
UA (1) UA79736C2 (de)
WO (1) WO2002024754A1 (de)
ZA (1) ZA200301692B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
FR2874924B1 (fr) * 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
US8183228B2 (en) * 2005-10-10 2012-05-22 MSD OSS B.V. Netherlands Anticoagulant antithrombotic dual inhibitors comprising a biotin label
BRPI0617215A2 (pt) * 2005-10-10 2011-07-19 Organon Nv composto anti-trombótico, composição farmacêutica, e, uso do composto
CN1317035C (zh) * 2005-10-24 2007-05-23 天津大学 基于酰肼基的微粒表面多重生物功能因子组装方法
EP1886696A1 (de) * 2006-08-03 2008-02-13 Endotis Pharma Konjugate von antithrombin-bindende-oligosaccharid-derivate und therapeutische proteine
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
EP2233143A1 (de) 2009-03-24 2010-09-29 Sanofi-Aventis Verwendung von Idrabiotaparinux zur Senkung der Blutungsinzidenz bei einer Thrombosebehandlung
EP2145624A1 (de) 2008-07-18 2010-01-20 Sanofi-Aventis Verwendung von Idrabiotaparinux zur Senkung der Blutungsinzidenz bei einer Thrombosebehandlung
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935386B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine
WO2010029552A1 (en) * 2008-09-10 2010-03-18 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
US20100173907A1 (en) 2008-12-19 2010-07-08 Supernus Pharmaceuticals, Inc. Method of treatment of aggression
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle
JP6109574B2 (ja) 2009-12-18 2017-04-05 カタラン、フランス、バインハイム、ソシエテ、アノニムＣａｔａｌｅｎｔ Ｆｒａｎｃｅ Ｂｅｉｎｈｅｉｍ Ｓａ 合成オリゴサッカリドを含有する医薬経口剤形
CZ302669B6 (cs) * 2010-03-29 2011-08-24 Univerzita Palackého v Olomouci Efektivní zpusob biotinylace aminosloucenin pomocí syntézy na pevné fázi pro potreby afinitní chromatografie
CZ302510B6 (cs) * 2010-03-29 2011-06-22 Univerzita Palackého v Olomouci Efektivní zpusob biotinylace sloucenin s karboxylovou skupinou pomocí syntézy na pevné fázi pro potreby afinitní chromatografie
CA2793222C (en) 2010-03-31 2018-01-23 Supernus Pharmaceuticals, Inc. Stabilized formulations of cns compounds
FR2964660B1 (fr) * 2010-09-10 2012-09-28 Sanofi Aventis Nouveaux polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
JP2013537181A (ja) * 2010-09-10 2013-09-30 サノフイ 抗血栓活性及び改善された代謝安定性を有するビオチン化多糖類
EP2484366A1 (de) 2011-02-07 2012-08-08 Sanofi Idrabiotaparinux für die Behandlung von Lungenembolien und zur sekundären Vorbeugung von venösen thromboembolischen Erkrankungen
JP6051211B2 (ja) * 2011-06-17 2016-12-27 カルボミメティクス 半減期が短く活性が高い合成五糖類
EP3524251A1 (de) * 2012-11-13 2019-08-14 Supernus Pharmaceuticals, Inc. Verfahren zur behandlung von aggression
WO2015195404A1 (en) 2014-06-20 2015-12-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for detection of an analyte by movement of tethered microparticles
WO2016205239A1 (en) 2015-06-15 2016-12-22 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Non-hormonal mammalian sperm decoy contraception based on the n-terminus of the zp2 protein
WO2018076025A1 (en) 2016-10-21 2018-04-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Molecular nanotags
CN108976318B (zh) * 2017-06-01 2021-03-30 首都医科大学 单-6-(生物素酰胺基)-6-脱氧-β-环糊精及其制备方法和应用
WO2019133727A1 (en) 2017-12-29 2019-07-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Universal influenza virus probe set for enrichment of any influenza virus nucleic acid
EP3997238A1 (de) 2019-07-09 2022-05-18 Optimvia, LLC Verfahren zur synthese von antikoagulierenden polysacchariden
US20230047654A1 (en) * 2019-10-17 2023-02-16 Autonetworks Technologies, Ltd. Wiring module
WO2022056078A1 (en) 2020-09-11 2022-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rnase h-assisted detection assay for rna (radar)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960884A (en) * 1974-04-24 1976-06-01 Sergei Ivanovich Zavyalov Method of preparing racemic biotin
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
WO2000002050A1 (en) * 1998-07-07 2000-01-13 Department Of Radiation Oncology, University Of Washington Trifunctional reagent for conjugation to a biomolecule
US20010023288A1 (en) * 1999-07-07 2001-09-20 Wilbur D. Scott Trifunctional reagent for conjugation to a biomolecule
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773804B1 (fr) * 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2773801B1 (fr) * 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
GB2335490B (en) * 1998-03-20 2003-05-14 Ortho Clinical Diagnostics An assay surface that permits an analyte releasiing step
DE69918523T2 (de) 1998-07-31 2005-07-28 Seikagaku Corp. Neues glycosaminoglycan und dieses enthaltendes arzneimittel
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
ECSP034514A (es) 2003-04-25
FR2814463B1 (fr) 2002-11-15
DE60130669T2 (de) 2008-07-17
US20060160768A1 (en) 2006-07-20
MXPA03002483A (es) 2004-05-24
BG66191B1 (bg) 2011-12-30
PL206727B1 (pl) 2010-09-30
SI1322673T1 (sl) 2008-02-29
WO2002024754A8 (fr) 2003-07-03
AU2001291960B2 (en) 2007-03-01
CA2418815A1 (en) 2002-03-28
MEP23608A (en) 2010-06-10
US7943595B2 (en) 2011-05-17
KR20080049139A (ko) 2008-06-03
CY1108076T1 (el) 2014-02-12
RS50730B (sr) 2010-08-31
US20110144042A1 (en) 2011-06-16
BR0114007A (pt) 2003-08-12
KR20030055269A (ko) 2003-07-02
NO20110401L (no) 2003-05-22
DK1322673T3 (da) 2008-01-14
IL154848A (en) 2010-11-30
NO332905B1 (no) 2013-01-28
SK287218B6 (sk) 2010-03-08
JP5016778B2 (ja) 2012-09-05
EP1322673A1 (de) 2003-07-02
AU2001291960C1 (en) 2009-10-08
EA200300237A1 (ru) 2003-08-28
PL363368A1 (en) 2004-11-15
EP1322673B1 (de) 2007-09-26
CZ2003814A3 (cs) 2003-06-18
UA79736C2 (uk) 2007-07-25
SK3562003A3 (en) 2003-11-04
TWI308153B (en) 2009-04-01
KR100891388B1 (ko) 2009-04-02
HU1400034D0 (hu) 2004-03-01
ES2292625T3 (es) 2008-03-16
HUP0303551A3 (en) 2004-03-29
JP2004509902A (ja) 2004-04-02
BG107650A (bg) 2003-11-28
US20040024197A1 (en) 2004-02-05
NO20031295D0 (no) 2003-03-20
NO20031295L (no) 2003-05-22
NZ524472A (en) 2004-10-29
HRP20030219B1 (en) 2011-10-31
ATE374215T1 (de) 2007-10-15
US6844329B2 (en) 2005-01-18
AU9196001A (en) 2002-04-02
AR030774A1 (es) 2003-09-03
IS2550B (is) 2009-10-15
CA2418815C (en) 2011-05-10
IL154848A0 (en) 2003-10-31
FR2814463A1 (fr) 2002-03-29
ZA200301692B (en) 2004-03-01
US8318696B2 (en) 2012-11-27
EE200300114A (et) 2005-02-15
JP2012131809A (ja) 2012-07-12
ME00080B (me) 2010-10-10
HK1053316A1 (en) 2003-10-17
CN1235914C (zh) 2006-01-11
SK287054B6 (sk) 2009-10-07
YU19703A (sh) 2006-05-25
CN1466594A (zh) 2004-01-07
EE05202B1 (et) 2009-08-17
CZ300856B6 (cs) 2009-08-26
EA005133B1 (ru) 2004-12-30
GEP20053616B (en) 2005-09-26
WO2002024754A1 (fr) 2002-03-28
IS6733A (is) 2003-02-28
HRP20030219A2 (en) 2003-06-30
PT1322673E (pt) 2007-12-03
PE20020471A1 (es) 2002-06-01
HUP0303551A2 (hu) 2004-03-01

Similar Documents

Publication Publication Date Title
DE60130669D1 (de) Polysaccharide mit antithrombotischer wirkung, die mit biotin oder einem biotenderivat kovalent gebunden sind
DE69838562D1 (de) Leistungsanpassung in einem mehrstationsnetzwerk
DE50112833D1 (de) Fahrzeug mit einem zu öffnenden fahrzeugdach
DE59810673D1 (de) Kraftwerksanlage mit einem CO2-Prozess
DE60314482D1 (de) Hämodynamikanalyse, insbesondere in einem Herzschrittmacher
DE502004003248D1 (de) Solarkollektor
DE60325556D1 (de) Kollektor mit hohem Wirkungsgrad
AU2003242624A1 (en) Linking to a page
DE60032728D1 (de) Kolben mit einem metallischen verbundwerkstoff
DE60220436D1 (de) Microkügelchen mit einem pleuromutilin-derivat
FR2847621B1 (fr) Turbine hydraulique a aubes
DE59101946D1 (de) Stauwerk, insbesondere für die absperrung eines tidewasserlaufes bei sturmflut.
IT1307422B1 (it) Metodo per produrre un cilindro separatore.
ATA5492002A (de) Turbine mit einem stromabwärts anschliessenden rohr
FI990641A0 (fi) Menetelmä kaupankäynnin tehostamiseen
DE60021924T2 (de) Polysaccharide mit immunostimulierender aktivität
FR2834895B1 (fr) Compositions dermatologiques, resistantes a l'eau, avec filtres solaires, procede de fabrication et utilisations de ces compositions
FR2845021B1 (fr) Presse a decouper
TH84005EX (th) ครอบปิดหลังคา
PT9906U (pt) Veiculo adaptado a proteccao solar
ITRG20000003U1 (it) Collettore solare a rendimento variabile.
DE60302690T2 (de) Mit einem Drainagesystem verbundener diaphysealer Verschlussstopfen
FI20002639A0 (fi) Aurinkokerääjä
ITRM20020437A0 (it) Concentratore rifrattivo a prismi per luce solare.
TH42451EX (th) เครื่องเก็บตัวอย่างน้ำ

Legal Events

Date Code Title Description
8364 No opposition during term of opposition